Article Details
Retrieved on: 2024-12-12 19:33:44
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses how Insilico Medicine used generative AI, specifically the Chemistry42 engine, to develop a gut-restricted PHD inhibitor for treating inflammatory bowel diseases like ulcerative colitis. This highlights AI's potential in advancing treatment for gastrointestinal and autoimmune diseases.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here